D.L. Venton

807 total citations
38 papers, 672 citations indexed

About

D.L. Venton is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, D.L. Venton has authored 38 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 15 papers in Organic Chemistry and 12 papers in Molecular Biology. Recurrent topics in D.L. Venton's work include Inflammatory mediators and NSAID effects (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). D.L. Venton is often cited by papers focused on Inflammatory mediators and NSAID effects (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). D.L. Venton collaborates with scholars based in United States. D.L. Venton's co-authors include Guy C. Le Breton, Leslie V. Parise, Perry V. Halushka, Michel Lagarde, Carole A. Parent, Elizabeth R. Hall, Larry D. Brace, Pierre Fonlupt, Patrick G. Swann and Martine Croset and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

D.L. Venton

36 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.L. Venton United States 14 246 219 163 119 109 38 672
Norman Whittaker United Kingdom 13 430 1.7× 302 1.4× 145 0.9× 234 2.0× 403 3.7× 27 1.1k
Yoshiyuki Inada Japan 15 192 0.8× 522 2.4× 412 2.5× 152 1.3× 413 3.8× 35 1.4k
Sudershan K. Sanduja United States 11 218 0.9× 158 0.7× 66 0.4× 77 0.6× 83 0.8× 20 496
Arie Derksen United States 13 148 0.6× 333 1.5× 84 0.5× 171 1.4× 24 0.2× 17 823
Earl G. Burton United States 16 281 1.1× 339 1.5× 28 0.2× 98 0.8× 217 2.0× 26 956
Xavier de Leval Belgium 25 557 2.3× 415 1.9× 163 1.0× 160 1.3× 422 3.9× 46 1.4k
H. Gleispach Austria 19 174 0.7× 361 1.6× 27 0.2× 137 1.2× 33 0.3× 66 867
Richard Sulsky United States 12 135 0.5× 640 2.9× 103 0.6× 69 0.6× 203 1.9× 18 1.1k
Thorsten J. Maier Germany 14 190 0.8× 247 1.1× 41 0.3× 93 0.8× 64 0.6× 24 670
Marie A. Holahan United States 22 68 0.3× 278 1.3× 206 1.3× 58 0.5× 173 1.6× 50 1.1k

Countries citing papers authored by D.L. Venton

Since Specialization
Citations

This map shows the geographic impact of D.L. Venton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.L. Venton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.L. Venton more than expected).

Fields of papers citing papers by D.L. Venton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.L. Venton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.L. Venton. The network helps show where D.L. Venton may publish in the future.

Co-authorship network of co-authors of D.L. Venton

This figure shows the co-authorship network connecting the top 25 collaborators of D.L. Venton. A scholar is included among the top collaborators of D.L. Venton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.L. Venton. D.L. Venton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woodbury, Charles P., et al.. (1998). Pulsed Ultrafiltration Characterization of Binding. Analytical Biochemistry. 261(2). 164–182. 13 indexed citations
2.
3.
4.
Komiotis, Dimitri, et al.. (1992). PgH2 analogs as potential antiplatelet derivatives. Journal of Medicinal Chemistry. 35(16). 3033–3039. 4 indexed citations
5.
Parent, Carole A., Michel Lagarde, D.L. Venton, & Guy C. Le Breton. (1992). Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.. Journal of Biological Chemistry. 267(10). 6541–6547. 26 indexed citations
6.
Swann, Patrick G., Carole A. Parent, Martine Croset, et al.. (1990). Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function.. Journal of Biological Chemistry. 265(35). 21692–21697. 61 indexed citations
7.
Schilling, Alexander, et al.. (1986). Ammonia (NH3 and N2H3) direct chemical ionization mass spectrometry of underivatized prostaglandin-H2 and other selected stable prostaglandins. Journal of Mass Spectrometry. 13(10). 545–551. 8 indexed citations
8.
Brace, Larry D., D.L. Venton, & Guy C. Le Breton. (1985). Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets. American Journal of Physiology-Heart and Circulatory Physiology. 249(1). H1–H7. 22 indexed citations
9.
Parise, Leslie V., D.L. Venton, & Guy C. Le Breton. (1984). Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 240–244. 61 indexed citations
10.
Breton, Guy C. Le, et al.. (1984). Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 80–84. 6 indexed citations
11.
Venton, D.L., et al.. (1984). Entrapment of a highly specific antiprogesterone antiserum using polysiloxane copolymers. Biochimica et Biophysica Acta (BBA) - General Subjects. 797(3). 343–347. 26 indexed citations
12.
Hall, Elizabeth R., et al.. (1984). Positive-negative, chemical-ionization, direct exposure mass spectrometry of underivatized prostaglandins. Prostaglandins. 27(4). 645–652. 8 indexed citations
13.
Breton, Guy C. Le, et al.. (1984). Synthesis of [17,18-3H]trans-13-azaprostanoic acid. A labeled probe for the PGH2/TXA2 receptor. Prostaglandins. 27(6). 865–876. 6 indexed citations
14.
Venton, D.L., et al.. (1983). 2-(6-Carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation. Journal of Medicinal Chemistry. 26(7). 1056–1060. 3 indexed citations
15.
Parise, Leslie V., D.L. Venton, & Guy C. Le Breton. (1982). Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.. Journal of Pharmacology and Experimental Therapeutics. 222(1). 276–281. 12 indexed citations
16.
Venton, D.L., et al.. (1981). High-yielding synthesis of monoalkylhydrazines. The Journal of Organic Chemistry. 46(26). 5413–5414. 43 indexed citations
17.
Venton, D.L., et al.. (1979). ChemInform Abstract: AZAPROSTANOIC ACID DERIVATIVES. INHIBITORS OF ARACHIDONIC ACID INDUCED PLATELET AGGREGATION. Chemischer Informationsdienst. 10(51). 4 indexed citations
18.
Breton, Guy C. Le, et al.. (1979). 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.. Proceedings of the National Academy of Sciences. 76(8). 4097–4101. 95 indexed citations
19.
Venton, D.L., et al.. (1979). Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregation. Journal of Medicinal Chemistry. 22(7). 824–830. 31 indexed citations
20.
Venton, D.L., F. Kohen, & Raymond E. Counsell. (1973). Hypocholesterolemic agents. 10. Synthesis of some model azacholanic acids as potential regulators of steroid biosynthesis and metabolism. Journal of Medicinal Chemistry. 16(5). 571–573. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norman Whittaker Breakdown of academic impact, for papers by Yoshiyuki Inada Breakdown of academic impact, for papers by Sudershan K. Sanduja Breakdown of academic impact, for papers by Arie Derksen Breakdown of academic impact, for papers by Earl G. Burton Breakdown of academic impact, for papers by Xavier de Leval Breakdown of academic impact, for papers by H. Gleispach Breakdown of academic impact, for papers by Richard Sulsky Breakdown of academic impact, for papers by Thorsten J. Maier Breakdown of academic impact, for papers by Marie A. Holahan
Rankless by CCL
2026